{{Rsnum
|rsid=2603127
|Gene=MYH15
|Chromosome=3
|position=108524704
|Orientation=plus
|GMAF=0.1102
|Gene_s=MYH15
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 2.7 | 42.0 | 55.4
| HCB | 0.0 | 0.7 | 99.3
| JPT | 0.0 | 0.9 | 99.1
| YRI | 0.0 | 1.4 | 98.6
| ASW | 0.0 | 10.5 | 89.5
| CHB | 0.0 | 0.7 | 99.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 1.0 | 13.9 | 85.1
| LWK | 0.0 | 11.1 | 88.9
| MEX | 1.8 | 16.1 | 82.1
| MKK | 0.0 | 5.8 | 94.2
| TSI | 2.9 | 34.3 | 62.7
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22443383
|Trait=None
|Title=Genome wide association study for plasma levels of natural anticoagulant inhibitors and protein C anticoagulant pathway: the MARTHA project.
|RiskAllele=A
|Pval=0.000005
|OR=2.7900
|ORtxt=None
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}